NRP1 and systemic lupus erythematosus: Therapeutic targeting of NRP1‐expressing cells ameliorated disease indicators, giving future hope for a new approach in treating Th‐cell‐mediated systemic autoimmune disease, especially as human SLE patients were found to also have increased NRP1‐expressing Th cells.